SCHEMBL17355827

SCHEMBL17355827

O=C(/C=C/C(=O)Oc1cc(F)ccc1C(F)(F)F)Oc1cc(F)ccc1C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ MAOB P27338 4/20 0.41
▸ PPARG P37231 1/20 0.39
▸ MRGPRX4 Q96LA9 2/20 0.37
▸ IDO1 P14902 2/20 0.36
▸ CYP1A1 P04798 1/20 0.35
▸ CYP1B1 Q16678 1/20 0.35
▸ P2RY1 P47900 1/20 0.35
▸ CES2 O00748 1/20 0.35
▸ RBP4 P02753 1/20 0.35
▸ TTR P02766 1/20 0.35
▸ ESR1 P03372 1/20 0.35
▸ KMT2A Q03164 1/20 0.34
▸ HCAR2 Q8TDS4 1/20 0.34
▸ KIF11 P52732 1/20 0.33
▸ SLC6A2 P23975 1/20 0.33
▸ SLC6A4 P31645 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17355824 0.87 MRGPRX4 (0.46) KDM4EMAPTHPGDHSD17B10MAOB
SCHEMBL17355733 0.81 KDM4E (0.50) KDM4EMAPTHPGDHSD17B10PPARG
SCHEMBL17355661 0.80 MRGPRX4 (0.41) KDM4EMAPTHPGDHSD17B10MAOB
SCHEMBL17355821 0.80 PPARG (0.45) KDM4EMAPTPPARGMRGPRX4IDO1
SCHEMBL17355762 0.79 KDM4E (0.46) KDM4EMAPTHPGDHSD17B10PPARG
SCHEMBL17355790 0.78 NOTUM (0.41) MAPTPPARGMRGPRX4P2RY1RBP4
SCHEMBL6861521 0.76 PPARG (0.45) PPARGMRGPRX4IDO1P2RY1RBP4
SCHEMBL7151999 0.72 PPARG (0.37) PPARGMRGPRX4IDO1RBP4TTR
SCHEMBL17355829 0.72 KMT2A (0.49) KDM4EMAPTHPGDHSD17B10MAOB
SCHEMBL27917095 0.72 PPARG (0.39) PPARGMRGPRX4IDO1P2RY1RBP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150372349-A1 NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE UBE INDUSTRIES, LTD. (JP) 2015-12-24 — — US disclosed
US-20150372349-A1 NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE UBE INDUSTRIES, LTD. (JP) 2015-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150372349-A1 NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE HCN2, SCO2, HCN1 KDM4E 1067/4885MAPT 4452/4885HPGD 2190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback